Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT): study protocol for the development of a core outcome set

BACKGROUND: Type 2 diabetes is characterised by abnormal glucose metabolism, and treatment is aimed at normalising glycaemia. Outcomes measured in clinical trials should be meaningful to patients, health care professionals and researchers, yet there is heterogeneity in the outcomes used across trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Harman, Nicola L., Wilding, John, Curry, Dave, Harris, James, Logue, Jennifer, Pemberton, R. John, Perreault, Leigh, Thompson, Gareth, Tunis, Sean, Williamson, Paula R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081933/
https://www.ncbi.nlm.nih.gov/pubmed/30086771
http://dx.doi.org/10.1186/s13063-018-2805-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081933/
https://www.ncbi.nlm.nih.gov/pubmed/30086771
http://dx.doi.org/10.1186/s13063-018-2805-2

Ejemplares similares